Home Institutions UCSF clinical trials Institution Directory
Clinical trials at UCSF Sites in San Francisco, CA
Institution pages show live ClinicalTrials.gov records that list this campus as a study site, whoever sponsors them. They do not rate, rank, or describe the institution.
ClinicalTrials.gov public records Last synced Oct 23, 2026, 1:42 PM EDT
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official matching trials
1395
Current sort
Recently updated
Campus scope
UCSF, San Francisco, CA
Additional filters apply within this campus.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
Showing 613–624 of 1,395 matching trials with a site at UCSF, San Francisco, CA.
Live ClinicalTrials.gov results.
Local aggregate panels are unavailable or hidden for filtered views. The result list above identifies its data source.
Live official records
Conditions Acute Myeloid Leukemia, Down Syndrome, Myelodysplastic Syndrome, Myeloid Leukemia Associated With Down Syndrome, Myeloproliferative Neoplasm
Interventions Asparaginase, Asparaginase Erwinia chrysanthemi, Cytarabine, Daunorubicin Hydrochloride, Etoposide, Laboratory Biomarker Analysis, Mitoxantrone Hydrochloride, Thioguanine Drug · Other
Lead sponsor Children's Oncology Group Network
Eligibility 91 Days to 3 Years
Enrollment 280 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2015 – 2027
U.S. locations 169
States / cities Birmingham, Alabama • Anchorage, Alaska • Mesa, Arizona + 131 more
Conditions Hemophilia A
Interventions PF-07055480 (giroctocogene fitelparovec): Recombinant AAV2/6 Human Factor VIII Gene Therapy Biological
Lead sponsor Pfizer Industry
Eligibility 18 Years to 64 Years · Male only
Enrollment 77 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2020 – 2026
U.S. locations 19
States / cities Mountain View, California • Oakland, California • Palo Alto, California + 5 more
Conditions Mucopolysaccharidosis II
Interventions Long-term Follow-Up Other
Lead sponsor REGENXBIO Inc. Industry
Eligibility Male only
Enrollment 27 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2021 – 2028
U.S. locations 3
States / cities San Francisco, California • New Brunswich, New Jersey • Philadelphia, Pennsylvania
Conditions Mitral Regurgitation
Interventions HARPOON™ Beating Heart Mitral Valve Repair System Device
Lead sponsor Edwards Lifesciences Industry
Eligibility 21 Years and older
Enrollment 25 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2020 – 2027
U.S. locations 9
States / cities San Francisco, California • Atlanta, Georgia • Baltimore, Maryland + 5 more
Conditions COVID-19, SARS-CoV-2 Infection
Interventions CoTend-BXBB (SARS2-30404), CoTend-s3BXBB (SARS2-17032), Placebo Biological
Lead sponsor Kara Chew Other
Eligibility 40 Years to 64 Years
Enrollment 80 participants
Healthy volunteers Accepts healthy volunteers
Timeline 2025 – 2029
U.S. locations 2
States / cities Los Angeles, California • San Francisco, California
Conditions Melanoma Stage III, Melanoma Stage IV
Interventions Binimetinib, Imatinib Drug
Lead sponsor University of California, San Francisco Other
Eligibility 18 Years and older
Enrollment 25 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2021 – 2028
U.S. locations 2
States / cities La Jolla, California • San Francisco, California
Conditions Knee Osteoarthristis, Cartilage Damage, Platelet Rich Plasma, Platelet Rich Plasma Injection
Interventions Platelet Rich Plasma, Emcyte PurePRP Supraphysiologic Concentrating System, APEX Biologix XCELL PRP System Biological · Device
Lead sponsor University of California, San Francisco Other
Eligibility 18 Years and older
Enrollment 20 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2026 – 2028
U.S. locations 1
States / cities San Francisco, California
Conditions Melanoma, Cutaneous Malignant
Interventions IMA203, nivolumab plus relatlimab, lifileucel, nivolumab, pembrolizumab, ipilimumab, Dacarbazine, temozolomide, paclitaxel, paclitaxel plus carboplatin, Albumin-Bound Paclitaxel Biological · Drug
Lead sponsor Immatics US, Inc. Industry
Eligibility 18 Years and older
Enrollment 360 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2025 – 2031
U.S. locations 43
States / cities Phoenix, Arizona • Scottsdale, Arizona • Duarte, California + 35 more
Conditions Recurrent World Health Organization (WHO) Grade II Glioma, Low-grade Glioma, High-Grade Glioma (HGG)
Interventions Everolimus, Trametinib Drug
Lead sponsor University of California, San Francisco Other
Eligibility 1 Year to 25 Years
Enrollment 50 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2020 – 2027
U.S. locations 17
States / cities Birmingham, Alabama • Los Angeles, California • San Diego, California + 14 more
Conditions NK-Cell Lymphoma, NK-Cell Leukemia, Peripheral T Cell Lymphoma
Interventions Methotrexate, pralatraxate,, Ifosfamide, Dexamethasone, Etoposide, calaspargase pegol, cyclophosphamide, Doxorubicin, Prednisone, Brentuximab Vedotin Drug
Lead sponsor New York Medical College Other
Eligibility 1 Year to 31 Years
Enrollment 40 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2019 – 2028
U.S. locations 6
States / cities Birmingham, Alabama • Orange, California • San Francisco, California + 3 more
Conditions Advanced Solid Malignancies
Interventions GIM122 Drug
Lead sponsor Georgiamune Inc Industry
Eligibility 18 Years and older
Enrollment 111 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2023 – 2026
U.S. locations 11
States / cities Los Angeles, California • San Francisco, California • Sarasota, Florida + 6 more
Conditions Brain Disorders, Aicardi Syndrome
Interventions Not listed
Lead sponsor University of California, San Francisco Other
Eligibility Not listed
Enrollment 2,000 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2003 – 2027
U.S. locations 1
States / cities San Francisco, California About this UCSF institution page
What this page lists ClinicalTrials.gov records that list UCSF in San Francisco, CA as a study site, whoever sponsors them, among recruiting, not yet recruiting, and active not recruiting trials.
Site status A study's overall status can differ from this site's status. Sites marked withdrawn, terminated, or completed are not counted here. Each record shows the status listed for this site when the official record provides one.
Where the data comes from Records are sourced from the official ClinicalTrials.gov public API. Each result links back to the official study page, which is the source of truth for eligibility, enrollment, and contact information.
What this page does not do No medical advice, eligibility judgments, ranking of trials, or AI-generated medical summaries. This page does not rank or rate institutions.
Related: all institution pages , trials led by University of California, San Francisco at any site , browse by condition , or browse by U.S. city .